Taiwan J Ophthalmol. 2020 Oct 19;11(3):287-291. doi: 10.4103/tjo.tjo_25_20. eCollection 2021.
Efficacy of probing adjunctive with low-dose mitomycin-C irrigation for the treatment of epiphora in adults with nasolacrimal duct stenosis.
Taiwan journal of ophthalmology
Babak Masoomian, Bahram Eshraghi, Golshan Latifi, Hossein Esfandiari
Affiliations
Affiliations
- Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
PMID: 34703745
PMCID: PMC8493988 DOI: 10.4103/tjo.tjo_25_20
Abstract
PURPOSE: The purpose of the study was to investigate the efficacy of adjunctive low-dose mitomycin-C (MMC) during successful lacrimal duct probing in adults with nasolacrimal ducts (NLDs) stenosis.
MATERIALS AND METHODS: This is a prospective case-control study on patients with NLD stenosis who were randomized into two groups. All patients underwent probing without or with an application of MMC. Former group received 0.2 mg/ml MMC irrigation for 5 min. The main outcome measures were objective evaluation of patency with irrigation, as well as patients' subjective assessment of improvement.
RESULTS: There were 73 eyes in 58 consecutive patients; patient mean age ranged from 19 to 78 years (mean 44 years). Female included larger group of patients (63%) and mean duration of the symptoms was 26.1 months (range, 2-120 months). After mean follow-up of 11 months (range, 9-14 months), 23 (60%) of the 38 eyes in the MMC groups and 8 (22%) of the 35 eyes in control group had complete response and remained symptom free. This difference was statistically significant (
CONCLUSION: This study suggests acceptable long-term results for probing adjunctive with MMC irrigation for adults with NLD stenosis that can be recommended as a simple and effective procedure for these patients.
Copyright: © 2020 Taiwan J Ophthalmol.
Keywords: Adults; epiphora; mitomycin-C; nasolacrimal duct stenosis; probing
Conflict of interest statement
The authors declare that there are no conflicts of interests of this paper.
References
- Ophthalmic Plast Reconstr Surg. 1999 Jan;15(1):19-22 - PubMed
- Eye (Lond). 2008 Dec;22(12):1483-7 - PubMed
- Ophthalmology. 2003 Feb;110(2):306-10 - PubMed
- Ophthalmology. 2002 Jan;109(1):172-4 - PubMed
- J Ocul Pharmacol Ther. 2014 Oct;30(8):615-24 - PubMed
- Br J Ophthalmol. 1998 Apr;82(4):389-91 - PubMed
- Indian J Ophthalmol. 2015 Apr;63(4):335-9 - PubMed
- Chonnam Med J. 2015 Apr;51(1):19-25 - PubMed
- Ophthalmic Plast Reconstr Surg. 2005 Mar;21(2):142-7 - PubMed
- Ophthalmic Plast Reconstr Surg. 2007 Nov-Dec;23(6):455-8 - PubMed
- Br J Ophthalmol. 2006 Apr;90(4):435-6 - PubMed
- Br J Ophthalmol. 2000 Aug;84(8):903-6 - PubMed
- Trans Ophthalmol Soc U K. 1986;105 ( Pt 4):494-7 - PubMed
- Ophthalmology. 1995 Jan;102(1):84-90 - PubMed
- Ophthalmic Surg Lasers. 1997 Apr;28(4):300-4 - PubMed
- Ophthalmology. 1992 Nov;99(11):1647-54 - PubMed
- Orbit. 2019 Jun;38(3):187-191 - PubMed
- Am J Ophthalmol. 1999 May;127(5):616-7 - PubMed
- Br J Ophthalmol. 1995 May;79(5):439-41 - PubMed
- Br J Ophthalmol. 2015 Oct;99(10):1396-400 - PubMed
Publication Types